Trials / Completed
CompletedNCT01976611
Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Chronic Migraine in Korea
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 402 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a Post-Marketing Surveillance study in Korea to evaluate the safety and efficacy of botulinum toxin Type A to treat Chronic Migraine in clinical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | botulinum toxin Type A | Botulinum toxin Type A treatment for chronic migraine as per local standard of care in clinical practice. |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2015-02-01
- Completion
- 2015-02-01
- First posted
- 2013-11-06
- Last updated
- 2015-04-08
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01976611. Inclusion in this directory is not an endorsement.